Kaneko MK - Search Results

1

Current Targeted Therapy for Metastatic Colorectal Cancer.

Ohishi T, Kaneko MK, Yoshida Y, Takashima A, Kato Y, Kawada M. Ohishi T, et al. Among authors: kaneko mk. Int J Mol Sci. 2023 Jan 15;24(2):1702. doi: 10.3390/ijms24021702. Int J Mol Sci. 2023. PMID: 36675216 Free PMC article. Review.

2

Molecular characterization of a human monoclonal antibody to B antigen in ABO blood type.

Kaneko M, Kato Y, Horiuchi H, Osawa M. Kaneko M, et al. Immunol Lett. 2003 Mar 3;86(1):45-51. doi: 10.1016/s0165-2478(02)00294-8. Immunol Lett. 2003. PMID: 12600744

3

Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors.

Kato Y, Fujita N, Kunita A, Sato S, Kaneko M, Osawa M, Tsuruo T. Kato Y, et al. J Biol Chem. 2003 Dec 19;278(51):51599-605. doi: 10.1074/jbc.M309935200. Epub 2003 Oct 1. J Biol Chem. 2003. PMID: 14522983 Free article.

4

Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors.

Kato Y, Sasagawa I, Kaneko M, Osawa M, Fujita N, Tsuruo T. Kato Y, et al. Oncogene. 2004 Nov 4;23(52):8552-6. doi: 10.1038/sj.onc.1207869. Oncogene. 2004. PMID: 15361850

5

Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma.

Kato Y, Kaneko M, Sata M, Fujita N, Tsuruo T, Osawa M. Kato Y, et al. Tumour Biol. 2005 Jul-Aug;26(4):195-200. doi: 10.1159/000086952. Epub 2005 Jul 7. Tumour Biol. 2005. PMID: 16006773

6

Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.

Suzuki-Inoue K, Kato Y, Inoue O, Kaneko MK, Mishima K, Yatomi Y, Yamazaki Y, Narimatsu H, Ozaki Y. Suzuki-Inoue K, et al. Among authors: kaneko mk. J Biol Chem. 2007 Sep 7;282(36):25993-6001. doi: 10.1074/jbc.M702327200. Epub 2007 Jul 6. J Biol Chem. 2007. PMID: 17616532 Free article. Clinical Trial.

7

Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma.

Suzuki H, Kato Y, Kaneko MK, Okita Y, Narimatsu H, Kato M. Suzuki H, et al. Among authors: kaneko mk. FEBS Lett. 2008 Jan 23;582(2):341-5. doi: 10.1016/j.febslet.2007.12.028. Epub 2007 Dec 26. FEBS Lett. 2008. PMID: 18158922 Free article.

8

Neutralization of blood group A-antigen by a novel anti-A antibody: overcoming ABO-incompatible solid-organ transplantation.

Hasegawa Y, Kato Y, Kaneko MK, Ogasawara S, Shimazu M, Tanabe M, Kawachi S, Obara H, Shinoda M, Kitagawa Y, Narimatsu H, Kitajima M. Hasegawa Y, et al. Among authors: kaneko mk. Transplantation. 2008 Feb 15;85(3):378-85. doi: 10.1097/TP.0b013e3181612f84. Transplantation. 2008. PMID: 18322429

9

Podocalyxin expression in malignant astrocytic tumors.

Hayatsu N, Kaneko MK, Mishima K, Nishikawa R, Matsutani M, Price JE, Kato Y. Hayatsu N, et al. Among authors: kaneko mk. Biochem Biophys Res Commun. 2008 Sep 19;374(2):394-8. doi: 10.1016/j.bbrc.2008.07.049. Epub 2008 Jul 17. Biochem Biophys Res Commun. 2008. PMID: 18639524

10

Characterization of anti-podoplanin monoclonal antibodies: critical epitopes for neutralizing the interaction between podoplanin and CLEC-2.

Ogasawara S, Kaneko MK, Price JE, Kato Y. Ogasawara S, et al. Among authors: kaneko mk. Hybridoma (Larchmt). 2008 Aug;27(4):259-67. doi: 10.1089/hyb.2008.0017. Hybridoma (Larchmt). 2008. PMID: 18707544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page